DPDoctor's PassportEducation
Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.
RapidMLAMSRAFoundation

Subclinical hypothyroidism

Essential points for quick revision.

!
Escalate

Subclinical hypothyroidism does not itself cause an acute thyroid emergency. Urgently reassess the diagnosis when free T4 is low, there is hypothermia or physiological compromise, pituitary disease is possible, or pregnancy is confirmed, because those situations follow different pathways.

Synopsis

Confirm a persistent raised-TSH normal-free-T4 pattern, estimate likelihood of progression and benefit, and use treatment trials or surveillance without medicalising transient results.

  • Subclinical hypothyroidism is a persistently raised TSH with free T4 inside the assay reference range after transient and analytical causes are excluded.
  • Confirm the abnormality on two samples separated by about three months before treatment in a stable non-pregnant adult, unless a different urgent context applies.
  • NICE advises considering levothyroxine when TSH is 10 mIU/L or higher on two measurements three months apart.

Key red flags

Overt disease instead

A free T4 below range means overt hypothyroidism, not subclinical disease. Marked clinical deterioration, hypothermia, bradycardia or reduced consciousness requires urgent evaluation regardless of an earlier mild profile.

Investigation priorities

01
Repeat TSH and free T4First step

Confirm persistence and exclude evolution to overt deficiency.

Management branches

ConfirmationValidate the subclinical label

A stable adult has raised TSH with free T4 within range.

  1. Review acute illness, pregnancy possibility, medicines, supplements, prior thyroid treatment and the magnitude and chronology of TSH elevation.
  2. Repeat TSH and free T4 after approximately three months in the routine pathway, adding TPO antibodies once when autoimmune disease status is informative.
SurveillanceObserve without losing follow-up

Treatment is not indicated, not beneficial or not preferred.

Key medicines

Levothyroxine for persistent subclinical hypothyroidismSelect an individual once-daily starting dose using age, body size, TSH elevation and cardiovascular disease; titrate in small steps against TSH and the current BNF rather than using a universal regimen.
Open full textbook Answer 2 questions
Sources and review status4 sources · checked 27 Aug 2026 · clinical review pending
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom